Hurtenbach U, Sachs D H, Shearer G M
J Exp Med. 1981 Dec 1;154(6):1922-34. doi: 10.1084/jem.154.6.1922.
Injection of parental spleen cells into unirradiated F1 hybrid mice results in suppression of the potential to generate cytotoxic T lymphocyte (CTL) responses in vitro. In an attempt to protect the F1 mice from immunosuppression, the recipients were injected with antibodies specific for major histocompatibility complex (MHC)-encoded antigens of the F1 mice 24 h before inoculation of the parental spleen cells. 8-14 d later, the generation of CTL responses in vitro against H-2 alloantigens was tested. Alloantiserum directed against either parental haplotype of the F1 strain markedly diminished the suppression of CTL activity. Furthermore, monoclonal antibodies recognizing H-2 or Ia antigens protected the F2 mice from parental spleen cell-induced suppression. Although this study has been limited to reagents that recognize host H-2 determinants, these findings do not necessarily imply that protection against graft vs. host (GvH) can be achieved only with anti-MHC antibodies. However, protection was observed only by antibodies reactive with F1 antigens, and small amounts of the alloantibodies were sufficient to diminish CTL suppression. Adoptive transfer of spleen cells from syngeneic F1 mice treated with anti-h-2a alloantiserum 24 h previously provided protection equal to that of injection of the recipients with alloantibodies. The cells necessary for this effect were shown to be T cells and to be radiosensitive to 2000 rad. This cell population is induced by antisera against F1 cell surface antigens and effectively counteracts GvH-associated immuno-suppression.
将亲代脾细胞注射到未受照射的F1杂种小鼠体内会导致体外产生细胞毒性T淋巴细胞(CTL)反应的能力受到抑制。为了保护F1小鼠免受免疫抑制,在接种亲代脾细胞前24小时给受体注射针对F1小鼠主要组织相容性复合体(MHC)编码抗原的特异性抗体。8 - 14天后,检测体外针对H - 2同种异体抗原的CTL反应的产生情况。针对F1品系任一亲代单倍型的同种抗血清显著减弱了CTL活性的抑制。此外,识别H - 2或Ia抗原的单克隆抗体保护F2小鼠免受亲代脾细胞诱导的抑制。尽管这项研究仅限于识别宿主H - 2决定簇的试剂,但这些发现不一定意味着仅用抗MHC抗体就能实现对移植物抗宿主(GvH)的保护。然而,仅观察到与F1抗原反应的抗体具有保护作用,少量的同种抗体就足以减弱CTL抑制。预先用抗h - 2a同种抗血清处理24小时的同基因F1小鼠脾细胞的过继转移提供了与给受体注射同种抗体相同的保护作用。这种效应所需的细胞被证明是T细胞,并且对2000拉德的辐射敏感。这个细胞群体由针对F1细胞表面抗原的抗血清诱导产生,并能有效对抗与GvH相关的免疫抑制。